XYone Therapeutics Marks Major Milestone with First Patient Dosed in XYA02 Clinical Trial #United_States #Canton #XYone_Therapeutics #XYA02 #MUC1-C
@newsen.bsky.socialExplore
@newsen.bsky.social
@newsen.bsky.socialXYone Therapeutics Marks Major Milestone with First Patient Dosed in XYA02 Clinical Trial #United_States #Canton #XYone_Therapeutics #XYA02 #MUC1-C